If you’re pregnant or preparing for pregnancy, you’ve likely come across guidance about folic acid or folate. These terms are sometimes used interchangeably, but they refer to related yet distinct forms of a B-vitamin that plays an important role in early fetal development. Understanding the difference — and what current research suggests about them — can help you have more informed conversations with your prenatal care provider.
The B-vitamin in question (vitamin B9) is naturally found in foods as folate and is synthesized as folic acid in supplements and fortified foods. The nuances of how the body processes each form have become the subject of growing research, and the conversation around which form is most beneficial is evolving.
This article explores what the evidence currently shows about folate and folic acid in pregnancy, why this nutrient matters, and what considerations may be worth raising with your healthcare provider.
Why Folate Matters in Early Pregnancy
Folate plays a central role in DNA synthesis and cell division — processes that are especially active during early fetal development. According to the Centers for Disease Control and Prevention (CDC), adequate folate intake in the weeks before and during early pregnancy is associated with a reduced risk of neural tube defects (NTDs) — serious birth defects affecting the brain, spine, or spinal cord that develop in the first few weeks of pregnancy, often before many women know they are pregnant.
This is why supplementation is typically recommended to begin before conception rather than waiting until a positive pregnancy test. The neural tube closes in the first 28 days after conception, making early folate availability particularly important.
Folic Acid: The Synthetic Form
Folic acid is the synthetic, oxidized form of B9 found in most prenatal vitamins and fortified foods (such as cereals, bread, and pasta in the United States, which have been fortified with folic acid since 1998). It is well-studied, widely available, and has decades of research supporting its role in reducing NTD risk when taken as recommended.
The MTHFR Consideration
A significant body of emerging research has focused on a common genetic variation called MTHFR (methylenetetrahydrofolate reductase), which affects the body’s ability to convert folic acid into its active, usable form (5-methyltetrahydrofolate, or 5-MTHF). Estimates suggest that a notable portion of the population carries one or two copies of MTHFR variants, though the clinical significance of these variants is an area of ongoing debate among researchers and clinicians. For individuals with certain MTHFR variants, the conversion of synthetic folic acid may be less efficient, which has prompted interest in methylated folate supplements.
Methylfolate: The Active Form
Methylfolate (5-MTHF) is the biologically active form of folate that the body can use directly, without the conversion step required for folic acid. It is available in some prenatal vitamins and supplements, often labeled as “methylfolate,” “5-MTHF,” or “L-methylfolate.”
Research comparing folic acid and methylfolate in pregnancy is still developing, and current evidence is not yet sufficient to make broad recommendations to switch from folic acid to methylfolate for the general population. Some healthcare providers do recommend methylfolate for patients known to have certain MTHFR variants or who have had previous NTD-affected pregnancies. This is a nuanced area where individual clinical guidance matters considerably.
Dietary Sources of Folate
Food sources of folate include dark leafy greens (spinach, kale, romaine lettuce), legumes (lentils, chickpeas, black beans), asparagus, Brussels sprouts, avocado, and fortified grains and cereals. While a diet rich in these foods can contribute meaningfully to folate intake, research generally supports supplementation in addition to dietary folate during the preconception period and first trimester, rather than relying on diet alone.
For a broader look at prenatal nutrition after 35, exploring the full range of nutrients relevant to pregnancy — beyond folate alone — can be useful context for conversations with your care team.
Current Recommendations and What They Mean
The CDC and most major obstetric guidelines currently recommend 400–800 micrograms of folic acid daily for women of reproductive age who could become pregnant, and higher doses (typically 4 milligrams) for women with a personal or family history of NTDs or other specific risk factors. Your healthcare provider can advise on the appropriate amount for your individual circumstances.
If you have questions about MTHFR variants, methylfolate supplementation, or your specific prenatal vitamin formulation, raising these directly with your OB/GYN or midwife — and potentially with a registered dietitian with prenatal nutrition expertise — is the most appropriate path. The supplement market in this area is active and not always well-regulated, making professional guidance especially valuable.
Understanding what questions to bring to your first prenatal appointment after 35 can help you make the most of early pregnancy care conversations.
Frequently Asked Questions
When should I start taking folate or folic acid?
Most guidelines recommend beginning supplementation at least one month before attempting to conceive, given the importance of folate in the very early weeks of fetal development. If your pregnancy was unplanned and you weren’t supplementing beforehand, beginning supplementation as soon as you know you’re pregnant and discussing timing with your provider is generally recommended.
Can I get enough folate from food alone without supplements?
While a folate-rich diet is valuable, research suggests that most women are unlikely to consistently consume sufficient amounts through food alone to meet the elevated recommendations for pregnancy. Supplementation is therefore generally recommended in addition to dietary folate, not as a replacement for a healthy diet.
Should everyone take methylfolate instead of folic acid?
Current evidence does not support a universal switch from folic acid to methylfolate for all pregnant women. For individuals with specific MTHFR variants or who have had previous NTD-affected pregnancies, some providers may recommend methylfolate, but this is a personalized clinical decision. Discuss your individual situation with your healthcare provider before changing supplementation.
Is too much folate harmful?
Very high folate intake — particularly from supplements — has been the subject of some research exploring potential concerns. The tolerable upper intake level for folic acid is set at 1,000 micrograms per day from fortified foods and supplements for adults. Women with specific risk factors may be prescribed higher doses under medical supervision. Following your provider’s recommendations and avoiding exceeding suggested doses without guidance is advisable.
Key Takeaways
- Folate (food form) and folic acid (synthetic supplement form) are related but distinct — folic acid requires conversion to the active form in the body, while methylfolate (5-MTHF) is the active, ready-to-use form.
- Adequate folate intake before and during early pregnancy is associated with reduced risk of neural tube defects, making preconception supplementation important.
- The MTHFR genetic variant may affect folic acid conversion efficiency, and some providers recommend methylfolate for individuals with certain variants — but this is an individualized recommendation.
- Most guidelines recommend beginning folate/folic acid supplementation at least one month before attempting conception.
- Discuss your specific supplementation needs, including whether methylfolate might be appropriate for you, with your healthcare provider.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.